Clinical Trial Update: A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 pharmacokinetic study of multiple oral doses of TNP-2092 capsules in healthy subjects, with Helicobacter pylor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• TNP-2092

Snippet

Sponsor: TenNor Therapeutics (Suzhou) Limited | Conditions: Helicobacter Pylori Infection | Phase 1 | Status: COMPLETED | Results posted: 2025-01-29